BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Bank of America
BAC
|
+$254M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$178M |
| 3 |
Kellanova
K
|
+$128M |
| 4 |
Pfizer
PFE
|
+$100M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$99M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$288M |
| 4 |
Procter & Gamble
PG
|
+$261M |
| 5 |
Apple
AAPL
|
+$214M |
Sector Composition
| 1 | Financials | 12.99% |
| 2 | Technology | 10.02% |
| 3 | Communication Services | 8.45% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Healthcare | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Hope Bancorp
HOPE
$1.4B
| $625K | ﹤0.01% |
28,535
+5,825
| +26% | +$128K |
|
1302
Enovis
ENOV
$1.81B
| $623K | ﹤0.01% |
10,078
-524
| -5% | -$32.4K |
|
1303
Glacier Bancorp
GBCI
$5.8B
| $620K | ﹤0.01% |
17,109
+5,121
| +43% | +$186K |
|
1304
FTI Consulting
FCN
$5.32B
| $619K | ﹤0.01% |
13,732
+4,780
| +53% | +$215K |
|
1305
Chemed
CHE
$6.5B
| $618K | ﹤0.01% |
3,852
+383
| +11% | +$61.4K |
|
1306
Allete
ALE
$3.67B
| $616K | ﹤0.01% |
9,598
+1,794
| +23% | +$115K |
|
1307
PIMCO Active Bond Exchange-Traded Fund
BOND
$5.88B
| $616K | ﹤0.01% |
5,916
-51
| -0.9% | -$5.31K |
|
1308
New York Times
NYT
$9.59B
| $616K | ﹤0.01% |
46,307
+22,385
| +94% | +$298K |
|
1309
LivaNova
LIVN
$3.07B
| $616K | ﹤0.01% |
13,690
+8,005
| +141% | +$360K |
|
1310
Vanguard Real Estate ETF
VNQ
$34.8B
| $609K | ﹤0.01% |
7,380
-750
| -9% | -$61.9K |
|
|
AKRX
1311
DELISTED
Akorn, Inc.
AKRX
| $609K | ﹤0.01% |
27,876
+19,742
| +243% | +$431K |
|
|
CRZO
1312
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $604K | ﹤0.01% |
16,169
+7,599
| +89% | +$284K |
|
|
CEB
1313
DELISTED
CEB Inc.
CEB
| $602K | ﹤0.01% |
9,934
+4,071
| +69% | +$247K |
|
|
FINL
1314
DELISTED
Finish Line
FINL
| $600K | ﹤0.01% |
31,917
+24,039
| +305% | +$452K |
|
1315
Green Plains
GPRE
$631M
| $600K | ﹤0.01% |
21,551
-1,491
| -6% | -$41.5K |
|
|
BCPC
1316
Balchem Corporation
BCPC
$5.07B
| $600K | ﹤0.01% |
7,148
+2,316
| +48% | +$194K |
|
|
DNR
1317
DELISTED
Denbury Resources, Inc.
DNR
| $598K | ﹤0.01% |
162,471
+70,744
| +77% | +$260K |
|
1318
Core Laboratories
CLB
$581M
| $597K | ﹤0.01% |
4,975
-835
| -14% | -$100K |
|
1319
MKS Inc. Common Stock
MKSI
$7.73B
| $596K | ﹤0.01% |
10,039
+234
| +2% | +$13.9K |
|
1320
Unifirst Corp
UNF
$3.18B
| $596K | ﹤0.01% |
4,146
+1,235
| +42% | +$177K |
|
1321
Columbia Banking Systems
COLB
$7.8B
| $595K | ﹤0.01% |
13,324
+3,056
| +30% | +$137K |
|
1322
Ligand Pharmaceuticals
LGND
$3.23B
| $594K | ﹤0.01% |
9,371
+4,533
| +94% | +$287K |
|
1323
LCI Industries
LCII
$2.43B
| $594K | ﹤0.01% |
5,512
+1,128
| +26% | +$122K |
|
|
POLY
1324
DELISTED
Plantronics, Inc.
POLY
| $593K | ﹤0.01% |
10,820
+4,059
| +60% | +$222K |
|
|
VQT
1325
DELISTED
iPath S&P VEQTOR ETN
VQT
| $592K | ﹤0.01% |
4,332
| – | – |
|